Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Shcheblyakov, Dmitry V.
82  Ergebnisse:
Personensuche X
?
1

Real-world clinical effectiveness of Tixagevimab/Cilgavimab..:

Fomina, Daria S. ; Lebedkina, Marina S. ; Iliukhina, Anna A....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Single-domain antibody delivery using an mRNA platform prot..:

Panova, Eugenia A. ; Kleymenov, Denis A. ; Shcheblyakov, Dmitry V....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Safety and immunogenicity of rAd26 and rAd5 vector-based he..:

Tukhvatulin, Amir I. ; Dolzhikova, Inna V. ; Dzharullaeva, Alina S....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

rAAV expressing recombinant antibody for emergency preventi..:

Esmagambetov, Ilias B. ; Ryabova, Ekaterina I. ; Derkaev, Artem A....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Retention of Neutralizing Response against SARS-CoV-2 Omicr..:

Lapa, Daniele ; Grousova, Daria M. ; Matusali, Giulia...
Vaccines.  10 (2022)  5 - p. 817 , 2022
Link: https://doi.org/10.3390/..
 
?
6

Estimation of anti-orthopoxvirus immunity in Moscow residen..:

Gushchin, Vladimir A. ; Ogarkova, Darya A. ; Dolzhikova, Inna V....
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:

Voronina, Daria V. ; Shcheblyakov, Dmitry V. ; Favorskaya, Irina A....
Viruses.  14 (2022)  11 - p. 2485 , 2022
Link: https://doi.org/10.3390/..
 
?
8

rAAV expressing recombinant neutralizing antibody for the b..:

Derkaev, Artem A. ; Ryabova, Ekaterina I. ; Esmagambetov, Ilias B....
Frontiers in Microbiology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
9

Immunogenicity and protectivity of intranasally delivered v..:

Tukhvatulin, Amir I. ; Gordeychuk, Ilya V. ; Dolzhikova, Inna V....
Emerging Microbes & Infections.  11 (2022)  1 - p. 2229-2247 , 2022
Link: https://doi.org/10.1080/..
 
?
10

Sputnik V protection from COVID-19 in people living with HI..:

Gushchin, Vladimir A. ; Tsyganova, Elena V. ; Ogarkova, Darya A....
eClinicalMedicine.  46 (2022)  - p. 101360 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Revaccination in Age-Risk Groups with Sputnik V Is Immunolo..:

Godkov, Mikhail A. ; Ogarkova, Darya A. ; Gushchin, Vladimir A....
Vaccines.  11 (2022)  1 - p. 90 , 2022
Link: https://doi.org/10.3390/..
 
?
12

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:

Favorskaya, Irina A. ; Shcheblyakov, Dmitry V. ; Esmagambetov, Ilias B....
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
13

Neutralizing Activity of Sera from Sputnik V-Vaccinated Peo..:

Gushchin, Vladimir A. ; Dolzhikova, Inna V. ; Shchetinin, Alexey M....
Vaccines.  9 (2021)  7 - p. 779 , 2021
Link: https://doi.org/10.3390/..
 
?
14

Impact of pathogen reduction methods on immunological prope..:

Kostin, Alexander I. ; Lundgren, Maria N. ; Bulanov, Andrey Y....
Vox Sanguinis.  116 (2021)  6 - p. 665-672 , 2021
Link: https://doi.org/10.1111/..
 
?
15

An open, non-randomised, phase 1/2 trial on the safety, tol..:

Tukhvatulin, Amir I. ; Dolzhikova, Inna V. ; Shcheblyakov, Dmitry V....
The Lancet Regional Health - Europe.  11 (2021)  - p. 100241 , 2021
Link: https://doi.org/10.1016/..
 
1-15